Nanoform Finland OYJ Logo

Nanoform Finland OYJ

Offers nanoparticle engineering services to enhance drug performance for pharma clients.

NANOFH | ST

Overview

Corporate Details

ISIN(s):
FI4000330972
LEI:
743700JJO2NU8LBS1592
Country:
Finland
Address:
Viikinkaari 4, FI-00790 HELSINKI

Description

Nanoform is a nanoparticle medicine enabling company that provides expert services in drug particle engineering to the global pharmaceutical and biotech industries. The company utilizes its proprietary, scalable Controlled Expansion of Supercritical Solutions (CESS®) technology to enhance the performance of both small and large molecule therapeutics. By creating uniform nanoparticles, Nanoform's services aim to improve drug bioavailability and solubility, enable higher drug loading in smaller dosage forms, and facilitate novel delivery routes such as subcutaneous, long-acting injectable, and inhaled formulations. The company partners with clients throughout the drug development lifecycle to overcome formulation challenges and reduce clinical trial attrition.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Nanoform Finland OYJ filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Nanoform Finland OYJ

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Nanoform Finland OYJ via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Kezar Life Sciences, Inc. Logo
Develops small molecule therapies for immune-mediated, liver, and oncologic disorders.
United States of America
KZR
Kidswell Bio Corporation Logo
Biopharmaceutical firm focused on R&D of therapeutics for pediatric healthcare.
Japan
4584
Kinarus Therapeutics Holding AG Logo
Acquires, develops, and commercializes medicines for rare and specialty diseases.
Switzerland
KNRS
Kiniksa Pharmaceuticals International, plc Logo
Develops immune-modulating therapies for autoimmune and cardiovascular diseases.
United States of America
KNSA
KIORA PHARMACEUTICALS INC Logo
Clinical-stage company developing advanced therapies for retinal diseases.
United States of America
KPRX
KISSEI PHARMACEUTICAL CO.,LTD. Logo
A research-driven pharmaceutical firm focused on urology, renal, and rare diseases.
Japan
4547
Klaria Pharma Holding AB Logo
Develops rapid-acting drugs using an oral film for transmucosal delivery.
Sweden
KLAR
Klotho Neurosciences, Inc. Logo
Develops gene and cell therapies for age-related neurodegenerative disorders.
United States of America
KLTO
KOA SHOJI HOLDINGS CO.,LTD. Logo
Imports, sells, and manufactures APIs and intermediates for the pharmaceutical industry.
Japan
9273
KOBAYASHI PHARMACEUTICAL  CO.,LTD. Logo
Develops, manufactures, and markets OTC pharmaceuticals, health, and household goods.
Japan
4967

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.